Log in to save to my catalogue

COVID-19: combining antiviral and anti-inflammatory treatments

COVID-19: combining antiviral and anti-inflammatory treatments

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7158903

COVID-19: combining antiviral and anti-inflammatory treatments

About this item

Full title

COVID-19: combining antiviral and anti-inflammatory treatments

Publisher

United States: Elsevier Ltd

Journal title

The Lancet infectious diseases, 2020-04, Vol.20 (4), p.400-402

Language

English

Formats

Publication information

Publisher

United States: Elsevier Ltd

More information

Scope and Contents

Contents

Both coronavirus disease 2019 (COVID-19) and severe acute respiratory syndrome (SARS) are characterised by an overexuberant inflammatory response and, for SARS, viral load is not correlated with the worsening of symptoms.1,2 In our previous Correspondence to The Lancet,3 we described how BenevolentAI's proprietary artificial intelligence (AI)-deriv...

Alternative Titles

Full title

COVID-19: combining antiviral and anti-inflammatory treatments

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7158903

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7158903

Other Identifiers

ISSN

1473-3099

E-ISSN

1474-4457

DOI

10.1016/S1473-3099(20)30132-8

How to access this item